Inventor · disambiguated record
Vincent Guerlavais
Also filed as: GUERLAVAIS VINCENT
24 granted patents·20 pending applications·694 citations·filing 2001–2024
96Inventor score
Files withAILERON THERAPEUTICS INC33MEDAREX INC3AETERNA ZENTARIS GMBH1AILERON THERAPEUTICS1BOYD SHARON E1
Top patents by PatentIndex Score
44 records- 0198US7517903B2Cytotoxic compounds and conjugatesMEDAREX INC·Filed 2005·Granted Apr 14, 2009·161 cites·19 claims
- 0296US8927500B2Peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2013·Granted Jan 6, 2015·44 cites·105 claims
- 0396US7691962B2Chemical linkers and conjugates thereofMEDAREX INC·Filed 2005·Granted Apr 6, 2010·200 cites·47 claims
- 0495US9957299B2Peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2016·Granted May 1, 2018·14 cites·22 claims
- 0595US9522947B2Peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2015·Granted Dec 20, 2016·25 cites·56 claims
- 0694US9096684B2Peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2012·Granted Aug 4, 2015·28 cites·38 claims
- 0793US10059741B2Peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2016·Granted Aug 28, 2018·10 cites·32 claims
- 0893US10023613B2Peptidomimetic macrocycles as modulators of MCL-1AILERON THERAPEUTICS INC·Filed 2016·Granted Jul 17, 2018·17 cites·17 claims
- 0993US8859723B2Peptidomimetic macrocyclesGUERLAVAIS VINCENT·Filed 2011·Granted Oct 14, 2014·33 cites·24 claims
- 1093US8461117B2Chemical linkers and cleavable substrates and conjugates thereofSUFI BILAL·Filed 2007·Granted Jun 11, 2013·61 cites·9 claims
- 1192US8987414B2Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2013·Granted Mar 24, 2015·30 cites·44 claims
- 1292US8664407B2Chemical linkers with single amino acids and conjugates thereofCHEN LIANG·Filed 2008·Granted Mar 4, 2014·26 cites·7 claims
- 1391US9505804B2Peptidomimetic macrocyclesAILERON THERAPEUTICS·Filed 2014·Granted Nov 29, 2016·22 cites·71 claims
- 1482US10967042B2Peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2018·Granted Apr 6, 2021·1 cites·18 claims
- 1581US6861409B2Growth hormone secretagoguesZENTARIS AG·Filed 2001·Granted Mar 1, 2005·13 cites·9 claims
- 1680US10213477B2Peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2016·Granted Feb 26, 2019·2 cites·21 claims
- 1780US2023119612A1Peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1875US10246491B2Peptidomimetic macrocycles and use thereof in regulating HIF1alphaAILERON THERAPEUTICS INC·Filed 2015·Granted Apr 2, 2019·1 cites·3 claims
- 1975US10227380B2Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2015·Granted Mar 12, 2019·2 cites·24 claims
- 2074US11008366B2Peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2019·Granted May 18, 2021·0 cites·11 claims
- 2174US10308699B2Peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2016·Granted Jun 4, 2019·1 cites·43 claims
- 2274US2022000968A1Peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2371US8399403B2Chemical linkers and conjugates thereofBOYD SHARON E·Filed 2009·Granted Mar 19, 2013·2 cites·13 claims
- 2469US2009326192A1Biologically active peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 2568US10703780B2Peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2018·Granted Jul 7, 2020·0 cites·17 claims
- 2665US2025171776A1Non-canonical cell-penetrating peptides for antisense oligomer deliverySAREPTA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2764US2014323701A1Biologically active peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 2864US2014378390A1Peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 2963US2017298099A1Biologically active peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3062US7297681B2Growth hormone secretagoguesAETERNA ZENTARIS GMBH·Filed 2004·Granted Nov 20, 2007·1 cites·17 claims
- 3162US2013023646A1Biologically active peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2012·Application pending·0 cites
- 3259US2016108089A1Biologically active peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 3357US2020369728A1Peptidomimetic macrocycles and uses thereofAILERON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3456US2023037284A9Combination therapy of peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3556US2019225650A1Peptidomimetic macrocycles and use thereof in regulating hif1alphaAILERON THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3655US2019292224A1Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3753US2011144303A1Biologically Active Peptidomimetic MacrocyclesAILERON THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 3851US11091522B2Peptidomimetic macrocycles and uses thereofAILERON THERAPEUTICS INC·Filed 2019·Granted Aug 17, 2021·0 cites·21 claims
- 3951US2017114098A1Peptidomimetic macrocycles and uses thereofAILERON THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4050US2018340009A1Peptidomimetic macrocycles as modulators of mcl-1AILERON THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4145US2018371021A1Peptidomimetic macrocycles and uses thereofAILERON THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4245US2019185518A9Warhead-containing peptidomimetic macrocycles as modulators of bfl-1AILERON THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4343US2008279868A1Antibody-Drug Conjugates and Methods of UseMEDAREX INC·Filed 2006·Application pending·0 cites
- 4436US2011223149A1Peptidomimetic macrocyclesAILERON THERAPEUTICS INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Vincent Guerlavais files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →